Back to search
Intensive Care Unit-acquired Weakness
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Intensive Care Unit-acquired Weakness trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Intensive Care Unit-acquired Weakness trials you may qualify forMulticenter, prospective, randomized controlled trial providing mobile health supported physical rehabilitation to 120 patients who have been critically ill wit…
The goal of this clinical trial is to study whether physical therapy can reduce NLRP3 inflammasome activation and muscle atrophy in patients with critical illne…
This study aims to evaluate the feasibility, usability, and clinical effectiveness of a digital rehabilitation platform in adult patients discharged from the in…
Up to 60% of patients admitted to the Intensive Care Unit (ICU) with a prolonged stay in the ICU develop complications such as intensive care unit acquired weak…
While mortality in U.S. pediatric intensive care units (PICUs) is improving, surviving children frequently develop persistent physical, cognitive, and psycholog…
This single-blind, three-group parallel randomized controlled trial will involve 138 patients with critical illness, randomly assigned at a 1:1:1 ratio to the t…
Purpose: to investigate the effect of Whole-body vibration versus neuro-muscular electrical stimulation on patients with intensive care-acquired weakness. Metho…
Older ICU survivors with ICU acquired weakness (ICUAW) are malnourished, sarcopenic, and functionally debilitated as a consequence of the high burden of comorbi…